DrugPipeline.net has announced the addition of “Europe Market Report for Treatment Planning Software 2017 - MedCore” research report to their website DrugPipeline.net.

Bangalore, Karnataka -- (SBWire) -- 03/17/2017 --General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

The treatment planning software market is characterized by aggressive ASP declines, resulting in relatively flat growth in terms of value. Treatment planning software is a relatively costly investment that holds the promise of improving dental implant procedure work flow and accuracy. The treatment planning software is generally purchased on a license basis, which requires annual renewals. Generally, experienced dental implant professionals regard this to be an unnecessary cost and shy away from its adoption. One notable example of this is the cost-sensitive market in Portugal.

In terms of annual sales of the software, growth has slowed down dramatically. As the excitement began to fade and the European economy did not recover from the recession, the market growth rate slowed down and began to stabilize. Growth is relatively low throughout Europe, with higher growth being demonstrated in smaller, less developed markets such as the United Kingdom. Unit growth is expected to continue to slow through the forecast period. Many doctors found the software did not amount to everything promised by the numerous sales pitches and marketing campaigns. Others found it difficult to use the software during implant procedures due to the extra cost of the surgical guides and the extra fees. The majority of software packages licensed are those bundled with implants, CT scanners or offered to the doctor as a complimentary benefit.

Computer guided surgery is a recent development within the dental implant market. The systems assist dentists in accurately placing dental implants. Computer guided surgery draws upon recent technological developments including three-dimensional radiographic imaging systems, CAD/CAM systems, rapid prototyping systems and imaging software. While this market is developing rapidly, especially as companies from all facets of the dental industry become involved, it remains a niche market segment, as the actual utilization of computer guided surgery systems is still quite low.

Spanning over 254 pages "Europe Market Report for Treatment Planning Software 2017 - MedCore" report covers Executive Summary, European Dental Implant Fixture And Final Abutment Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Assessment, Country Profiles, Treatment Planning Software Market, Appendix. The report covered companies are - Straumann, Dentsply Sirona, Nobel Biocare, Zimmer Biomet, CAMLOG, Sweden & Martina, Medentis, MIS Implants, BEGO, Others include: 3D Diagnostix, 3D Med, 3DIEMME, 3Shape, A.B. Dental, ACE Surgical, ADIN Dental Implant Systems, ADT Dental, Allmed, Alpha-BioTec, Anthogyr, Atec Dental, Avinent, Bicon, Biodenta, Biomain, Biotech, Blue Sky Bio, Bredent, BTI, Champions, Cortex Dental, Dental Wings, Dentatus, Dentium, DOT, Easy System Implant, Eckermann, Euroteknika, Global D, IDI, Implant Direct, Intra-Lock, JMP-Dental, Klockner, Leader Italia, Med3D, Medentis, MegaGen, Microdent, Mozo-Grau, Nemotec, Neodent, Neoss, Osstem, Phibo, Southern Implants, Swissmeda, TBR Implants Group, Thommen Medical, Timplant, Ziterion, etc.

For more information Visit at: http://www.drugpipeline.net/idata-research/europe-market-report-treatment-planning-software-2017-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.